Artivion (AORT) Stock: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$21.93
-0.89 (-3.90%)
▼
5d:
-4.78%
30d:
-19.05%
90d:
-8.51%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AORT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AORT shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.43
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.62
3.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $21.93, which is considered oversold relative to its 30-day fair value range of $23.29 to $26.40. From a valuation perspective, the stock is trading at a discount (Forward PE: 29.3) compared to its historical average (36.8). Remarkably, the market is currently pricing in an annual earnings decline of 7.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a uptrend. The price is currently testing key support at $21.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: AORT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $42.15 (+92.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AORT is in a uptrend. The price is currently testing key support at $21.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: AORT scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $42.15 (+92.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$23.29 -
$26.40
Company Quality Score
48/100
(HOLD)
Options IV Signal
59th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
55.8%
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 59th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 92.2% below Wall St target ($42.15)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.29 -
$26.40
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$3.13
(14.3%)
Support & Resistance Levels
Support Level
$21.86
Resistance Level
$24.76
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.31
Wall Street Target
$42.15
(+92.2%)
Revenue Growth (YoY)
11.3%
Profit Margin
-0.7%
Valuation Discount vs History
-7.3% cheaper
PE vs Historical
29.3 vs 36.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.3%
(market-implied from PE analysis)
1-Year Target
$20.33
(-7%)
2-Year Target
$18.85
(-14%)
3-Year Target
$17.47
(-20%)
3-Yr Target (if PE normalizes)
(PE: 29→37)
$21.94
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.3, Growth: 88.0%)
$74.01
(+238%)
Base:
(SPY PE: 20.4, Growth: 88.0%)
$51.52
(+135%)
Bear:
(PE: 17.3, Growth: 88.0%)
$43.79
(+100%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 29.3 to 36.8
Stabilization Target:
$27.54
(+25.6%)
PE Expansion Potential:
+25.6%
Share & Embed Analysis
Last updated: October 01, 2026 5:02 PM ET
Data refreshes hourly during market hours. Next update: 6:02 PM
Data refreshes hourly during market hours. Next update: 6:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 64 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 44 HOLD |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
